$ACRX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ACELRX PHARMACEUTICALS INC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in ACELRX PHARMACEUTICALS INC. Get notifications about new insider transactions in ACELRX PHARMACEUTICALS INC for free.

Page: < prev 1 2 3 4 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 15 2017	ACRX	ACELRX PHARMACEUTI ...	Afable Richard	Director	Option Exercise	A	2.30	15,000	34,500	15,000
Jun 15 2017	ACRX	ACELRX PHARMACEUTI ...	EDWARDS MARK G	Director	Option Exercise	A	2.30	15,000	34,500	15,000
Apr 11 2017	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Option Exercise	D	1.20	9,122	10,946	0
Apr 11 2017	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Grant	A	0.00	6,879	0	80,354	73.5 K to 80.4 K (+9.36 %)
Apr 11 2017	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Grant	A	1.20	9,122	10,946	73,475	64.4 K to 73.5 K (+14.17 %)
Mar 07 2017	ACRX	ACELRX PHARMACEUTI ...	Angotti Vincent J.	Chief Executive Off ...	Option Exercise	A	3.30	800,000	2,640,000	800,000
Feb 17 2017	ACRX	ACELRX PHARMACEUTI ...	Rosen Howard B	CEO	Option Exercise	A	3.00	366,000	1,098,000	366,000
Feb 09 2017	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Option Exercise	A	3.00	79,500	238,500	79,500
Feb 09 2017	ACRX	ACELRX PHARMACEUTI ...	MORRIS TIMOTHY E	Chief Financial Off ...	Option Exercise	A	3.00	112,500	337,500	112,500
Feb 09 2017	ACRX	ACELRX PHARMACEUTI ...	Dasu Badri N	Chief Engineering O ...	Option Exercise	A	3.00	79,500	238,500	79,500
Feb 09 2017	ACRX	ACELRX PHARMACEUTI ...	Mitchell Jane Wright	Chief Legal Officer	Option Exercise	A	3.00	79,500	238,500	79,500
Feb 09 2017	ACRX	ACELRX PHARMACEUTI ...	Palmer Pamela P	Chief Medical Offic ...	Option Exercise	A	3.00	132,500	397,500	132,500
Sep 30 2016	ACRX	ACELRX PHARMACEUTI ...	PERCEPTIVE ADVISORS LLC	10% Owner	Sell	S	3.88	97,200	377,117	5,386,410	5.5 M to 5.4 M (-1.77 %)
Sep 30 2016	ACRX	ACELRX PHARMACEUTI ...	PERCEPTIVE ADVISORS LLC	10% Owner	Sell	S	3.96	119,300	472,380	5,483,610	5.6 M to 5.5 M (-2.13 %)
Sep 16 2016	ACRX	ACELRX PHARMACEUTI ...	PERCEPTIVE ADVISORS LLC	10% Owner	Sell	S	3.63	115,923	420,511	5,602,910	5.7 M to 5.6 M (-2.03 %)
Sep 16 2016	ACRX	ACELRX PHARMACEUTI ...	PERCEPTIVE ADVISORS LLC	10% Owner	Sell	S	3.73	276,927	1,032,301	5,718,833	6 M to 5.7 M (-4.62 %)
Jun 22 2016	ACRX	ACELRX PHARMACEUTI ...	ADAMS ADRIAN	Director	Option Exercise	A	2.87	15,000	43,050	15,000
Jun 22 2016	ACRX	ACELRX PHARMACEUTI ...	HOFFMAN C STEVEN	Director	Option Exercise	A	2.87	15,000	43,050	15,000
Jun 22 2016	ACRX	ACELRX PHARMACEUTI ...	WAN MARK A	Director	Option Exercise	A	2.87	15,000	43,050	15,000
Jun 22 2016	ACRX	ACELRX PHARMACEUTI ...	Afable Richard	Director	Option Exercise	A	2.87	15,000	43,050	15,000
Jun 22 2016	ACRX	ACELRX PHARMACEUTI ...	EDWARDS MARK G	Director	Option Exercise	A	2.87	15,000	43,050	15,000
May 16 2016	ACRX	ACELRX PHARMACEUTI ...	Rosen Howard B	CEO	Buy	P	3.26	10,206	33,272	50,000	39.8 K to 50 K (+25.65 %)
May 12 2016	ACRX	ACELRX PHARMACEUTI ...	EDWARDS MARK G	Director	Buy	P	3.05	5,000	15,250	115,000	110 K to 115 K (+4.55 %)
May 12 2016	ACRX	ACELRX PHARMACEUTI ...	EDWARDS MARK G	Director	Buy	P	3.15	5,000	15,750	110,000	105 K to 110 K (+4.76 %)
May 12 2016	ACRX	ACELRX PHARMACEUTI ...	EDWARDS MARK G	Director	Buy	P	3.25	5,000	16,250	105,000	100 K to 105 K (+5.00 %)
Mar 30 2016	ACRX	ACELRX PHARMACEUTI ...	Rosen Howard B	CEO	Option Exercise	A	3.10	800,000	2,480,000	800,000
Feb 18 2016	ACRX	ACELRX PHARMACEUTI ...	Palmer Pamela P	Chief Medical Offic ...	Option Exercise	A	3.40	110,500	375,700	110,500
Feb 18 2016	ACRX	ACELRX PHARMACEUTI ...	MORRIS TIMOTHY E	Chief Financial Off ...	Option Exercise	A	3.40	110,500	375,700	110,500
Feb 18 2016	ACRX	ACELRX PHARMACEUTI ...	Mitchell Jane Wright	Chief Legal Officer	Option Exercise	A	3.40	90,000	306,000	90,000
Feb 18 2016	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Option Exercise	A	3.40	70,000	238,000	70,000
Feb 18 2016	ACRX	ACELRX PHARMACEUTI ...	Dasu Badri N	Chief Engineering O ...	Option Exercise	A	3.40	70,000	238,000	70,000
Nov 19 2015	ACRX	ACELRX PHARMACEUTI ...	PERCEPTIVE ADVISORS LLC	10% Owner	Sell	S	5.35	42,300	226,132	5,995,760	6 M to 6 M (-0.70 %)
Nov 19 2015	ACRX	ACELRX PHARMACEUTI ...	PERCEPTIVE ADVISORS LLC	10% Owner	Sell	S	5.36	133,900	717,409	6,038,060	6.2 M to 6 M (-2.17 %)
Nov 09 2015	ACRX	ACELRX PHARMACEUTI ...	PERCEPTIVE ADVISORS LLC	10% Owner	Sell	S	4.47	17,100	76,365	6,171,960	6.2 M to 6.2 M (-0.28 %)
Nov 09 2015	ACRX	ACELRX PHARMACEUTI ...	PERCEPTIVE ADVISORS LLC	10% Owner	Sell	S	4.62	75,000	346,260	6,189,060	6.3 M to 6.2 M (-1.20 %)
Sep 11 2015	ACRX	ACELRX PHARMACEUTI ...	PERCEPTIVE ADVISORS LLC	10% Owner	Sell	S	4.18	310,000	1,294,777	6,264,060	6.6 M to 6.3 M (-4.72 %)
Aug 21 2015	ACRX	ACELRX PHARMACEUTI ...	Palmer Pamela P	Chief Medical Offic ...	Option Exercise	M	2.56	29,000	74,240	221,000
Aug 21 2015	ACRX	ACELRX PHARMACEUTI ...	Palmer Pamela P	Chief Medical Offic ...	Buy	M	2.56	29,000	74,240	399,015	370 K to 399 K (+7.84 %)
Jun 24 2015	ACRX	ACELRX PHARMACEUTI ...	EDWARDS MARK G	Director	Option Exercise	A	4.08	15,000	61,200	15,000
Jun 24 2015	ACRX	ACELRX PHARMACEUTI ...	HOFFMAN C STEVEN	Director	Option Exercise	A	4.08	15,000	61,200	15,000
Jun 24 2015	ACRX	ACELRX PHARMACEUTI ...	WAN MARK A	Director	Option Exercise	A	4.08	15,000	61,200	15,000
Jun 24 2015	ACRX	ACELRX PHARMACEUTI ...	Afable Richard	Director	Option Exercise	A	4.08	15,000	61,200	15,000
Jun 24 2015	ACRX	ACELRX PHARMACEUTI ...	ADAMS ADRIAN	Director	Option Exercise	A	4.08	15,000	61,200	15,000
May 20 2015	ACRX	ACELRX PHARMACEUTI ...	Rosen Howard B	Intermin CEO	Buy	P	0.00	35,400	0	39,794	4.4 K to 39.8 K (+805.64 %)
May 07 2015	ACRX	ACELRX PHARMACEUTI ...	EDWARDS MARK G	Director	Buy	P	3.13	40,000	125,116	100,000	60 K to 100 K (+66.67 %)
May 01 2015	ACRX	ACELRX PHARMACEUTI ...	MORRIS TIMOTHY E	Chief Financial Off ...	Option Exercise	A	4.24	100,000	424,000	100,000
Apr 23 2015	ACRX	ACELRX PHARMACEUTI ...	Afable Richard	Director	Buy	P	10.30	1,000	10,300	1,000	0 to 1,000
Apr 03 2015	ACRX	ACELRX PHARMACEUTI ...	Rosen Howard B	Intermin CEO	Option Exercise	A	3.92	240,000	940,800	240,000
Mar 17 2015	ACRX	ACELRX PHARMACEUTI ...	Palmer Pamela P	Chief Medical Offic ...	Option Exercise	M	1.32	25,000	33,000	0
Mar 17 2015	ACRX	ACELRX PHARMACEUTI ...	Palmer Pamela P	Chief Medical Offic ...	Buy	M	1.32	25,000	33,000	370,015	345 K to 370 K (+7.25 %)
Dec 04 2014	ACRX	ACELRX PHARMACEUTI ...	Palmer Pamela P	Chief Medical Offic ...	Option Exercise	A	6.60	110,000	726,000	110,000
Dec 04 2014	ACRX	ACELRX PHARMACEUTI ...	MORRIS TIMOTHY E	Chief Financial Off ...	Option Exercise	A	6.60	100,000	660,000	100,000
Dec 04 2014	ACRX	ACELRX PHARMACEUTI ...	Mitchell Jane Wright	Chief Legal Officer	Option Exercise	A	6.60	70,000	462,000	70,000
Dec 04 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Option Exercise	A	6.60	70,000	462,000	70,000
Dec 04 2014	ACRX	ACELRX PHARMACEUTI ...	Dasu Badri N	Chief Engineering O ...	Option Exercise	A	6.60	70,000	462,000	70,000
Jul 28 2014	ACRX	ACELRX PHARMACEUTI ...	HOFFMAN C STEVEN	Director	Option Exercise	A	10.22	15,000	153,300	15,000
Jul 28 2014	ACRX	ACELRX PHARMACEUTI ...	EDWARDS MARK G	Director	Option Exercise	A	10.22	15,000	153,300	15,000
Jul 28 2014	ACRX	ACELRX PHARMACEUTI ...	Rosen Howard B	Director	Option Exercise	A	10.22	15,000	153,300	15,000
Jul 28 2014	ACRX	ACELRX PHARMACEUTI ...	Afable Richard	Director	Option Exercise	A	10.22	15,000	153,300	15,000
Jul 28 2014	ACRX	ACELRX PHARMACEUTI ...	ADAMS ADRIAN	Director	Option Exercise	A	10.22	15,000	153,300	15,000
Jul 25 2014	ACRX	ACELRX PHARMACEUTI ...	WAN MARK A	Director	Option Exercise	A	10.22	15,000	153,300	15,000
Jul 28 2014	ACRX	ACELRX PHARMACEUTI ...	Mitchell Jane Wright	Chief Legal Officer	Option Exercise	A	10.22	65,000	664,300	65,000
Jul 21 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Option Exercise	D	1.20	3,962	4,754	9,122
Jul 21 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Grant	A	9.57	1,000	9,570	64,353	65.4 K to 64.4 K (-1.53 %)
Jul 21 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Grant	A	1.20	3,962	4,754	65,353	61.4 K to 65.4 K (+6.45 %)
May 20 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Option Exercise	D	1.20	1,312	1,574	17,438
May 20 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Option Exercise	D	1.20	2,346	2,815	0
May 20 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Sell	D	8.84	1,000	8,840	58,037	59 K to 58 K (-1.69 %)
May 20 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Grant	A	1.20	3,658	4,390	59,037	55.4 K to 59 K (+6.61 %)
Jun 19 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Option Exercise	D	1.20	4,354	5,225	13,084
Jun 19 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Sell	D	10.51	1,000	10,510	61,391	62.4 K to 61.4 K (-1.60 %)
Jun 19 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Grant	A	1.20	4,354	5,225	62,391	58 K to 62.4 K (+7.50 %)
May 08 2014	ACRX	ACELRX PHARMACEUTI ...	MORRIS TIMOTHY E	Chief Financial Off ...	Option Exercise	A	10.34	200,000	2,068,000	200,000
Apr 18 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Option Exercise	D	1.20	4,329	5,195	2,346
Apr 18 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Sell	D	10.45	1,000	10,450	55,379	56.4 K to 55.4 K (-1.77 %)
Apr 18 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Grant	A	1.20	4,329	5,195	56,379	52.1 K to 56.4 K (+8.32 %)
Mar 19 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Option Exercise	D	1.20	2,305	2,766	6,675
Mar 19 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Option Exercise	D	1.20	2,911	3,493	0
Mar 19 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Sell	D	12.58	1,000	12,580	52,050	53.1 K to 52.1 K (-1.89 %)
Mar 19 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Grant	A	1.20	5,216	6,259	53,050	47.8 K to 53.1 K (+10.90 %)
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	EDWARDS MARK G	Director	Option Exercise	D	3.11	9,375	29,156	3,125
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	EDWARDS MARK G	Director	Option Exercise	D	3.25	11,666	37,915	3,334
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	EDWARDS MARK G	Director	Sell	D	12.15	21,041	255,636	60,000	81 K to 60 K (-25.96 %)
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	EDWARDS MARK G	Director	Grant	A	3.11	9,375	29,156	81,041	71.7 K to 81 K (+13.08 %)
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	EDWARDS MARK G	Director	Grant	A	3.25	11,666	37,915	71,666	60 K to 71.7 K (+19.44 %)
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	Dasu Badri N	Chief Engineering O ...	Payment of Exercise	F	11.43	1,380	15,773	22,530	23.9 K to 22.5 K (-5.77 %)
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	Dasu Badri N	Chief Engineering O ...	Sell	D	12.45	1,000	12,452	23,910	24.9 K to 23.9 K (-4.01 %)
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	KING RICHARD	Director	Payment of Exercise	F	11.43	11,599	132,577	134,567	146.2 K to 134.6 K (-7.94 %)
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Payment of Exercise	F	11.43	1,569	17,934	47,834	49.4 K to 47.8 K (-3.18 %)
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	WAN MARK A	Director	Sell	S	12.36	11,250	139,050	126,153	137.4 K to 126.2 K (-8.19 %)
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	WAN MARK A	Director	Sell	S	11.96	459	5,490	137,403	137.9 K to 137.4 K (-0.33 %)
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	WAN MARK A	Director	Sell	S	12.39	1,759	21,791	137,862	139.6 K to 137.9 K (-1.26 %)
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	WAN MARK A	Director	Sell	S	12.36	509,520	6,297,667	5,713,569	6.2 M to 5.7 M (-8.19 %)
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	WAN MARK A	Director	Sell	S	11.96	20,800	248,768	6,223,089	6.2 M to 6.2 M (-0.33 %)
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	WAN MARK A	Director	Sell	S	12.39	79,645	986,658	6,243,889	6.3 M to 6.2 M (-1.26 %)
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	WAN MARK A	Director	Sell	S	12.36	16,049	198,366	179,962	196 K to 180 K (-8.19 %)
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	WAN MARK A	Director	Sell	S	11.96	655	7,834	196,011	196.7 K to 196 K (-0.33 %)
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	WAN MARK A	Director	Sell	S	12.39	2,508	31,070	196,666	199.2 K to 196.7 K (-1.26 %)
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	WAN MARK A	Director	Sell	S	12.36	298,508	3,689,559	3,347,357	3.6 M to 3.3 M (-8.19 %)
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	WAN MARK A	Director	Sell	S	11.96	12,186	145,745	3,645,865	3.7 M to 3.6 M (-0.33 %)
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	WAN MARK A	Director	Sell	S	12.39	46,661	578,046	3,658,051	3.7 M to 3.7 M (-1.26 %)
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	HOFFMAN STEPHEN J	Director	Sell	J	0.00	1,300,000	0	2,871,933	4.2 M to 2.9 M (-31.16 %)
Mar 11 2014	ACRX	ACELRX PHARMACEUTI ...	Skyline Venture Partners Quali ...		Sell	J	0.00	1,300,000	0	2,871,933	4.2 M to 2.9 M (-31.16 %)
Feb 20 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Option Exercise	D	1.20	4,878	5,854	2,911
Feb 20 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Sell	D	11.77	1,000	11,770	46,880	47.9 K to 46.9 K (-2.09 %)
Feb 20 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Grant	A	1.20	4,878	5,854	47,880	43 K to 47.9 K (+11.34 %)
Feb 06 2014	ACRX	ACELRX PHARMACEUTI ...	KING RICHARD	Director	Option Exercise	A	10.34	175,000	1,809,500	175,000
Feb 06 2014	ACRX	ACELRX PHARMACEUTI ...	WELCH JAMES H	Chief Financial Off ...	Option Exercise	A	10.34	75,000	775,500	75,000
Feb 06 2014	ACRX	ACELRX PHARMACEUTI ...	Palmer Pamela P	Chief Medical Offic ...	Option Exercise	A	10.34	100,000	1,034,000	100,000
Feb 06 2014	ACRX	ACELRX PHARMACEUTI ...	Chung David	Chief Commercial Of ...	Option Exercise	A	10.34	25,000	258,500	25,000
Feb 06 2014	ACRX	ACELRX PHARMACEUTI ...	Dasu Badri N	Chief Engineering O ...	Option Exercise	A	10.34	60,000	620,400	60,000
Feb 06 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Option Exercise	A	10.34	60,000	620,400	60,000
Jan 22 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Option Exercise	D	1.20	5,283	6,340	11,847
Jan 22 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Sell	D	12.74	1,000	12,740	40,944	41.9 K to 40.9 K (-2.38 %)
Jan 22 2014	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Grant	A	1.20	5,283	6,340	41,944	36.7 K to 41.9 K (+14.41 %)
Dec 19 2013	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Option Exercise	D	1.20	4,058	4,870	13,072
Dec 19 2013	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Sell	D	9.80	1,000	9,800	38,719	39.7 K to 38.7 K (-2.52 %)
Dec 19 2013	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Grant	A	1.20	4,058	4,870	39,719	35.7 K to 39.7 K (+11.38 %)
Dec 12 2013	ACRX	ACELRX PHARMACEUTI ...	Afable Richard	Director	Option Exercise	A	8.18	15,000	122,700	15,000
Nov 20 2013	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Option Exercise	D	1.20	3,433	4,120	17,130
Nov 20 2013	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Sell	D	8.30	1,000	8,300	35,661	36.7 K to 35.7 K (-2.73 %)
Nov 20 2013	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Grant	A	1.20	3,433	4,120	36,661	33.2 K to 36.7 K (+10.33 %)
Nov 06 2013	ACRX	ACELRX PHARMACEUTI ...	PERCEPTIVE ADVISORS LLC	10% Owner	Buy	P	6.84	3,250	22,220	6,374,060	6.4 M to 6.4 M (+0.05 %)
Nov 06 2013	ACRX	ACELRX PHARMACEUTI ...	PERCEPTIVE ADVISORS LLC	10% Owner	Buy	P	6.84	46,750	319,630	6,370,810	6.3 M to 6.4 M (+0.74 %)
Nov 06 2013	ACRX	ACELRX PHARMACEUTI ...	PERCEPTIVE ADVISORS LLC	10% Owner	Buy	P	6.88	6,825	46,959	6,324,060	6.3 M to 6.3 M (+0.11 %)
Nov 06 2013	ACRX	ACELRX PHARMACEUTI ...	PERCEPTIVE ADVISORS LLC	10% Owner	Buy	P	6.88	98,175	675,483	6,317,235	6.2 M to 6.3 M (+1.58 %)
Nov 12 2013	ACRX	ACELRX PHARMACEUTI ...	PERCEPTIVE ADVISORS LLC	10% Owner	Buy	P	6.50	6,500	42,238	6,574,060	6.6 M to 6.6 M (+0.10 %)
Nov 12 2013	ACRX	ACELRX PHARMACEUTI ...	PERCEPTIVE ADVISORS LLC	10% Owner	Buy	P	6.50	93,500	607,572	6,567,560	6.5 M to 6.6 M (+1.44 %)
Nov 12 2013	ACRX	ACELRX PHARMACEUTI ...	PERCEPTIVE ADVISORS LLC	10% Owner	Buy	P	6.52	6,500	42,358	6,474,060	6.5 M to 6.5 M (+0.10 %)
Nov 12 2013	ACRX	ACELRX PHARMACEUTI ...	PERCEPTIVE ADVISORS LLC	10% Owner	Buy	P	6.52	93,500	609,302	6,467,560	6.4 M to 6.5 M (+1.47 %)
Nov 04 2013	ACRX	ACELRX PHARMACEUTI ...	PERCEPTIVE ADVISORS LLC	10% Owner	Buy	P	7.17	150,218	1,077,033	6,219,060	6.1 M to 6.2 M (+2.48 %)
Nov 04 2013	ACRX	ACELRX PHARMACEUTI ...	PERCEPTIVE ADVISORS LLC	10% Owner	Buy	P	7.17	10,442	74,867	6,068,842	6.1 M to 6.1 M (+0.17 %)
Nov 04 2013	ACRX	ACELRX PHARMACEUTI ...	PERCEPTIVE ADVISORS LLC	10% Owner	Buy	P	6.69	8,000	53,546	6,058,400	6.1 M to 6.1 M (+0.13 %)
Nov 04 2013	ACRX	ACELRX PHARMACEUTI ...	PERCEPTIVE ADVISORS LLC	10% Owner	Buy	P	6.69	192,000	1,285,094	6,050,400	5.9 M to 6.1 M (+3.28 %)
Oct 18 2013	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Option Exercise	D	1.20	3,520	4,224	20,563
Oct 18 2013	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Sell	D	8.54	1,000	8,540	33,228	34.2 K to 33.2 K (-2.92 %)
Oct 18 2013	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Grant	A	1.20	3,520	4,224	34,228	30.7 K to 34.2 K (+11.46 %)
Sep 23 2013	ACRX	ACELRX PHARMACEUTI ...	NOHRA GUY P	Director	Sell	S	10.84	96,519	1,046,131	2,507,974	2.6 M to 2.5 M (-3.71 %)
Sep 23 2013	ACRX	ACELRX PHARMACEUTI ...	NOHRA GUY P	Director	Sell	S	10.21	61,634	629,450	2,604,493	2.7 M to 2.6 M (-2.31 %)
Sep 19 2013	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Option Exercise	D	1.20	4,437	5,324	20,563
Sep 19 2013	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Sell	D	10.71	1,000	10,710	30,708	31.7 K to 30.7 K (-3.15 %)
Sep 19 2013	ACRX	ACELRX PHARMACEUTI ...	Hamel Lawrence G	Chief Development O ...	Grant	A	1.20	4,437	5,324	31,708	27.3 K to 31.7 K (+16.27 %)
Sep 18 2013	ACRX	ACELRX PHARMACEUTI ...	NOHRA GUY P	Director	Sell	S	10.29	62,461	642,480	2,666,127	2.7 M to 2.7 M (-2.29 %)
Sep 18 2013	ACRX	ACELRX PHARMACEUTI ...	NOHRA GUY P	Director	Sell	S	10.48	49,921	523,107	2,728,588	2.8 M to 2.7 M (-1.80 %)
Sep 18 2013	ACRX	ACELRX PHARMACEUTI ...	NOHRA GUY P	Director	Sell	S	10.75	16,398	176,221	2,778,509	2.8 M to 2.8 M (-0.59 %)
Sep 18 2013	ACRX	ACELRX PHARMACEUTI ...	Chung David	Chief Commercial Of ...	Option Exercise	A	10.55	150,000	1,582,500	150,000
Sep 16 2013	ACRX	ACELRX PHARMACEUTI ...	NOHRA GUY P	Director	Option Exercise	A	10.55	15,000	158,250	15,000
Sep 16 2013	ACRX	ACELRX PHARMACEUTI ...	ADAMS ADRIAN	Director	Option Exercise	P	10.55	15,000	158,250	15,000
Sep 16 2013	ACRX	ACELRX PHARMACEUTI ...	EDWARDS MARK G	Director	Option Exercise	A	10.55	15,000	158,250	15,000
Sep 16 2013	ACRX	ACELRX PHARMACEUTI ...	Rosen Howard B	Director	Option Exercise	A	10.55	15,000	158,250	15,000

Page: < prev 1 2 3 4 next >